Literature DB >> 12885948

DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias.

Nicoletta Ferrari1, Giulio L Palmisano, Laura Paleari, Giuseppe Basso, Manuela Mangioni, Vincenzo Fidanza, Adriana Albini, Carlo M Croce, Giovanni Levi, Claudio Brigati.   

Abstract

Dlx genes constitute a gene family thought to be essential in morphogenesis and development. We show here that in vertebrate cells, Dlx genes appear to be part of a regulatory cascade initiated by acute lymphoblastic leukemia (ALL)-1, a master regulator gene whose disruption is implicated in several human acute leukemias. The expression of Dlx2, Dlx3, Dlx5, Dlx6, and Dlx7 was absent in All-1 -/- mouse embryonic stem cells and reduced in All-1 +/- cells. In leukemic patients affected by the t(4;11)(q21;q23) chromosomal abnormality, the expression of DLX2, DLX3, and DLX4 was virtually abrogated. Our data indicate that Dlx genes are downstream targets of ALL-1 and could be considered as important tools for the study of the early leukemic cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885948     DOI: 10.1189/jlb.1102581

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  DLX4 is associated with orofacial clefting and abnormal jaw development.

Authors:  Di Wu; Shyamali Mandal; Alex Choi; August Anderson; Michaela Prochazkova; Hazel Perry; Vera L Gil-Da-Silva-Lopes; Richard Lao; Eunice Wan; Paul Ling-Fung Tang; Pui-yan Kwok; Ophir Klein; Bian Zhuan; Anne M Slavotinek
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

Review 2.  Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance.

Authors:  Ridwan Islam; Juhi Mishra; Sanika Bodas; Sreyashi Bhattacharya; Surinder K Batra; Samikshan Dutta; Kaustubh Datta
Journal:  Cancer Metastasis Rev       Date:  2022-07-01       Impact factor: 9.237

3.  Distal-less homeobox transcription factors regulate development and maturation of natural killer cells.

Authors:  John B Sunwoo; Sungjin Kim; Liping Yang; Tina Naik; Darryl A Higuchi; John L Rubenstein; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-29       Impact factor: 11.205

4.  Msx and dlx homeogene expression in epithelial odontogenic tumors.

Authors:  Blandine Ruhin-Poncet; Sonia Ghoul-Mazgar; Dominique Hotton; Frédérique Capron; Mohamed Habib Jaafoura; Gérard Goubin; Ariane Berdal
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

5.  Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.

Authors:  Peng Tang; Hua Huang; Jiang Chang; Gong-Fang Zhao; Ming-Liang Lu; Yan Wang
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

6.  Increased copy number of the DLX4 homeobox gene in breast axillary lymph node metastasis.

Authors:  Clarissa Torresan; Márcia M C Oliveira; Silma R F Pereira; Enilze M S F Ribeiro; Catalin Marian; Yuriy Gusev; Rubens S Lima; Cicero A Urban; Patricia E Berg; Bassem R Haddad; Iglenir J Cavalli; Luciane R Cavalli
Journal:  Cancer Genet       Date:  2014-05-02

7.  Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.

Authors:  Monica Morini; Simonetta Astigiano; Yorick Gitton; Laura Emionite; Valentina Mirisola; Giovanni Levi; Ottavia Barbieri
Journal:  BMC Cancer       Date:  2010-11-25       Impact factor: 4.430

8.  p53-R273H upregulates neuropilin-2 to promote cell mobility and tumor metastasis.

Authors:  Tao Lv; Xianqiang Wu; Lijuan Sun; Qingyong Hu; Yang Wan; Liang Wang; Zhiqiang Zhao; Xiao Tu; Zhi-Xiong Jim Xiao
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

9.  Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.

Authors:  Yeo-Jin Choi; Ga-Young Baek; Hae-Ran Park; Sung-Kee Jo; Uhee Jung
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.